Millstone Evans Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
1,385
+220
+19% +$225K 0.9% 20
2026
Q1
$1.07M Buy
1,165
+64
+6% +$64.9K 0.64% 28
2025
Q4
$1.18M Hold
1,101
0.7% 24
2025
Q3
$840K Hold
1,101
0.53% 32
2025
Q2
$858K Buy
1,101
+13
+1% +$10.1K 0.59% 33
2025
Q1
$899K Hold
1,088
0.61% 32
2024
Q4
$840K Buy
+1,088
New +$901K 0.57% 32

Other funds holding LLY

Millstone Evans Group's LLY Position: Q2 2026 in Review

Millstone Evans Group increased its Eli Lilly (LLY) stake by 19% in Q2 2026, buying an estimated $225K and bringing the position to 1,385 shares worth $1.66M. The position accounts for 0.9% of the portfolio, ranked #20.

Millstone Evans Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Millstone Evans Group held 1,385 shares of Eli Lilly worth $1.66M as of Q2 2026.
  • Millstone Evans Group bought 220 Eli Lilly shares in Q2 2026, an estimated $225K.
  • Eli Lilly made up 0.9% of Millstone Evans Group's portfolio in Q2 2026, its #20 holding.
  • Millstone Evans Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.